Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Colfax Corporation (CFX) stocks in Canada

Learn how to easily invest in Colfax Corporation stocks.

Colfax Corporation is a specialty industrial machinery business based in the US. Colfax Corporation stocks (CFX.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $46.65 – a decrease of 2.15% over the previous week. Colfax Corporation employs 15,400 staff and has a trailing 12-month revenue of around $3.7 billion.

How to buy shares in Colfax Corporation

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CFX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Is it a good time to buy Colfax Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

How has Coronavirus impacted Colfax Corporation's stock price?

Since the stock market crash in March caused by coronavirus, Colfax Corporation's stock price has had significant positive movement.

Its last market close was $44.11, which is 11.81% up on its pre-crash value of $38.9 and 260.67% up on the lowest point reached during the March crash when the stocks fell as low as $12.23.

If you had bought $1,000 worth of Colfax Corporation stocks at the start of February 2020, those stocks would have been worth $416.40 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,224.49.

Colfax Corporation stock price (NYSE:CFX)

Use our graph to track the performance of CFX stocks over time.

Colfax Corporation shares at a glance

Information last updated 2022-01-18.
Latest market close$44.11
52-week range$36.73 - $54.67
50-day moving average $47.32
200-day moving average $46.55
Wall St. target price$55.56
PE ratio 60.9195
Dividend yield N/A (0%)
Earnings per share (TTM) $0.71

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
3.8 / 5
$4.99 - $9.99
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
CIBC Investor's Edge
Finder Rating:
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get a $50 bonus when you open a new RRSP, TFSA or RESP and start pre-authorized contributions of $200+/month. Valid until March 1, 2022.

Compare up to 4 providers

Online stock trading

Colfax Corporation price performance over time

Historical closes compared with the close of $44.11 from 2022-01-18

1 week (2022-01-08) N/A
1 month (2021-12-17) 0.23%
3 months (2021-10-19) -12.41%
6 months (2021-07-19) 3.21%
1 year (2021-01-19) 11.42%
2 years (2020-01-17) 15.87%
3 years (2019-01-18) 84.72%
5 years (2017-01-19) 18.13%

Is Colfax Corporation under- or over-valued?

Valuing Colfax Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Colfax Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Colfax Corporation's P/E ratio

Colfax Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 61x. In other words, Colfax Corporation shares trade at around 61x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Colfax Corporation's PEG ratio

Colfax Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.7288. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Colfax Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Colfax Corporation's EBITDA

Colfax Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $579.3 million.

The EBITDA is a measure of a Colfax Corporation's overall financial performance and is widely used to measure a its profitability.

Colfax Corporation financials

Revenue TTM $3.7 billion
Operating margin TTM 8.79%
Gross profit TTM $1.3 billion
Return on assets TTM 2.66%
Return on equity TTM 294.45%
Profit margin 2.92%
Book value $29.63
Market capitalisation $6.9 billion

TTM: trailing 12 months

Colfax Corporation share dividends

We're not expecting Colfax Corporation to pay a dividend over the next 12 months.

Colfax Corporation share price volatility

Over the last 12 months, Colfax Corporation's shares have ranged in value from as little as $36.725 up to $54.67. A popular way to gauge a stock's volatility is its "beta".

CFX.US volatility(beta: 2.15)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Colfax Corporation's is 2.1505. This would suggest that Colfax Corporation's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Colfax Corporation overview

Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. It also provides welding consumables comprising electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, such as electrodes, nozzles, and shields and tips. This segment sells its products through independent distributors and direct sales to the infrastructure, wind power, marine/life sciences, pipelines, mobile/off-highway equipment, oil, gas, and mining markets principally under the ESAB brand. The Medical Technology segment develops, manufactures, and distributes medical device products used by orthopedic specialists, spine surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site